CA2348415C - Method for gold deposition - Google Patents
Method for gold deposition Download PDFInfo
- Publication number
- CA2348415C CA2348415C CA2348415A CA2348415A CA2348415C CA 2348415 C CA2348415 C CA 2348415C CA 2348415 A CA2348415 A CA 2348415A CA 2348415 A CA2348415 A CA 2348415A CA 2348415 C CA2348415 C CA 2348415C
- Authority
- CA
- Canada
- Prior art keywords
- gold
- substrate
- nucleation
- metal
- sites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 151
- 239000010931 gold Substances 0.000 title claims abstract description 135
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 133
- 238000000034 method Methods 0.000 title claims abstract description 81
- 230000008021 deposition Effects 0.000 title description 29
- 230000006911 nucleation Effects 0.000 claims abstract description 132
- 239000000758 substrate Substances 0.000 claims abstract description 112
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 98
- 238000010899 nucleation Methods 0.000 claims abstract description 59
- 229910052751 metal Inorganic materials 0.000 claims abstract description 58
- 239000002184 metal Substances 0.000 claims abstract description 58
- 239000012491 analyte Substances 0.000 claims abstract description 49
- 239000000203 mixture Substances 0.000 claims abstract description 48
- 238000000151 deposition Methods 0.000 claims abstract description 38
- 238000001514 detection method Methods 0.000 claims abstract description 12
- 239000000523 sample Substances 0.000 claims description 62
- 230000027455 binding Effects 0.000 claims description 36
- 239000000126 substance Substances 0.000 claims description 31
- 108091034117 Oligonucleotide Proteins 0.000 claims description 22
- 239000003153 chemical reaction reagent Substances 0.000 claims description 21
- 238000000926 separation method Methods 0.000 claims description 19
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 16
- 230000015572 biosynthetic process Effects 0.000 claims description 15
- 230000009870 specific binding Effects 0.000 claims description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 14
- 239000002773 nucleotide Substances 0.000 claims description 13
- 125000003729 nucleotide group Chemical group 0.000 claims description 13
- 239000000427 antigen Substances 0.000 claims description 12
- 102000036639 antigens Human genes 0.000 claims description 12
- 108091007433 antigens Proteins 0.000 claims description 12
- 239000002923 metal particle Substances 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 10
- 229920002678 cellulose Polymers 0.000 claims description 10
- 229960002685 biotin Drugs 0.000 claims description 9
- 239000011616 biotin Substances 0.000 claims description 9
- 238000003384 imaging method Methods 0.000 claims description 9
- 108010090804 Streptavidin Proteins 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- DTMHTVJOHYTUHE-UHFFFAOYSA-N thiocyanogen Chemical compound N#CSSC#N DTMHTVJOHYTUHE-UHFFFAOYSA-N 0.000 claims description 7
- 108090001008 Avidin Proteins 0.000 claims description 6
- 102000014914 Carrier Proteins Human genes 0.000 claims description 5
- 229920002101 Chitin Polymers 0.000 claims description 5
- 108020004635 Complementary DNA Proteins 0.000 claims description 5
- 102000004856 Lectins Human genes 0.000 claims description 5
- 108090001090 Lectins Proteins 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 5
- 108091008324 binding proteins Proteins 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000002523 lectin Substances 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N para-benzoquinone Natural products O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 4
- 238000001493 electron microscopy Methods 0.000 claims description 3
- 238000007794 visualization technique Methods 0.000 claims description 3
- 238000002835 absorbance Methods 0.000 claims description 2
- 238000004630 atomic force microscopy Methods 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 125000004151 quinonyl group Chemical group 0.000 claims description 2
- 238000004626 scanning electron microscopy Methods 0.000 claims description 2
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 claims 2
- 238000000149 argon plasma sintering Methods 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 17
- 238000003556 assay Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 7
- 238000012800 visualization Methods 0.000 description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 239000000084 colloidal system Substances 0.000 description 6
- 238000001465 metallisation Methods 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000000018 DNA microarray Methods 0.000 description 5
- 238000005137 deposition process Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 210000003463 organelle Anatomy 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- -1 silver ions Chemical class 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000005234 chemical deposition Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 238000000399 optical microscopy Methods 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 108091028026 C-DNA Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000006352 cycloaddition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000005289 physical deposition Methods 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
Abstract
A method for depositing gold on a substrate is provided. By this aspect, nucleation centers are bound, deposited or formed at one or more sites on the substrate, the substrate is then contacted with a treatment composition which comprises soluble gold-providing agent from which gold is deposited onto a nucleation center to yield gold metal deposits. The method of the invention may be used for a variety of image enhancing techniques as well as diagnostic and analyte detection techniques.
Description
METHOD FOR GOLD DEPOSITION
FIELD OF THE INVENTION
The invention relates to chemical deposition of gold metal on substrates.
BACKGROUND OF THE INVENTION
There are various techniques and uses in which metal substances are deposited on substrates. In various such methods, the metal to be deposited is provided in a form of a soluble complex or molecule, e.g. in an aqueous solution.
Under appropriate conditions the complex or molecule is reduced and deposits the metal onto the substrate.
At times, in order to ensure deposition of metal from solution onto a io substrate, it is preferable to first provide nucleation centers on the substrate. Such nucleation centers may, for example, be a variety of metal complexes, clusters or small metal particles, deposited on or attached to the surface.
Examples of techniques involving metal deposition are a variety of image formation or latent image contrast-enhancement techniques for photography, 15 optical microscopy or electron microscopy. Another example of laboratory techniques where metal complexes are deposited onto a substrate, is in imaging of separation products, e.g. proteins or nucleic acids, in a variety of chromatographic or electrophoretic techniques.
The metal most typically used in such techniques is silver. However, one 2o typical drawback of silver deposition is that the deposition is not completely specific and some degree of spontaneous deposition of silver may occur also without an a priori deposition of nucleation centers. Thus, where silver deposition is used in image-enhancement or contrast-enhancement methods, there is typically a limited signal-to-noise ratio.
_2_ GENERAL DESCRIPTION OF THE INVENTION
The present invention has, as one of its objects, the provision of a method for depositing gold onto specific sites on a substrate. Another object of the invention is to provide a composition and kit for use in such a method.
In accordance with the present invention gold, initially contained in a soluble gold-providing agent, being a gold-containing molecule, cluster or complex, is deposited onto nucleation centers. The term "nucleation centers "
as used herein refers to any salt, complex, cluster or particle having catalytic properties of transforming gold from a gold-containing molecule or complex into io gold metal. Particles with a metal surface are, for example, colloid metal particles, a variety of metal complexes, clusters containing metal atoms, etc.
In accordance with the invention there is provided a method for depositing gold at one or more sites on a substrate, comprising:
(a) binding, depositing or forming nucleation centers at said one or more 1 s sites;
(b) contacting said one or more sites with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable such that gold metal is essentially not deposited on the substrate unless a nucleation center is present on the substrate and in the presence of a 2o nucleation center at said one or more sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said one or more sites.
As will be appreciated, once gold is deposited on the substrate, it serves as a nucleation center for further gold deposition. By appropriately controlling the 2s incubation time as well as other conditions affecting the gold deposition (some of which will be outlined bellow), the amount of the deposited gold at a deposition site can be controlled. Furthermore, although the initial gold deposition may be at discrete sites on the substrate, by allowing the gold deposits to grow, following further deposition, discrete sites may combine to form one larger gold deposit 3o encompassing the so combined sites.
_3_ The term "essentially not deposited " means to denote that there is either no gold separation from the solution and the gold atoms remain within the soluble molecule or complex, or that gold metal deposition on a substrate is negligible and thus not or only hardly observable and measurable, yielding a high signal-to-noise s ratio.
In accordance with one embodiment, the nucleation centers are formed by chemical or physical deposition of nucleation center forming agent onto the one or more sites. By another embodiment, such nucleation centers may be formed chemically at said one or more sites by a redox reaction in which metal ions, in io particular silver ions, are oxidized into metallic silver. Such chemical formation of nucleation centers is known per se (see for example WO 99/04402 and PCT/IL99/00232).
In accordance with yet another embodiment, the nucleation centers are formed by binding of nucleation center-forming agents at said one or more sites.
is Such agents comprise at least one binding moiety with a binding affinity (which may be specific or non-specific) to said one or more sites, which is bound to at least one nucleation center moiety. The nucleation center moiety is a species that can act as a catalytic agent for gold metal deposition, e.g. a salt, metal particle, cluster of metal atoms or a metal-containing complex. The binding moiety may, for example, 2o be one member of a recognition group, where another member of the recognition group forms or is included in said one or more sites. The recognition group, typically a recognition couple, consists of two or more substances with a binding affinity one to the other. The recognition group may be, but is not limited to, any one of the following couples: an antigen and an antibody or an antibody derivative 25 with a complementary antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or synthetic binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain.
The nucleation center moiety is preferably a gold particle or a cluster ;o containing gold atoms, e.g. Aull or AuSS or Au~4~ (gold clusters that contain 11, 55 or 147 gold atoms, respectively). The treatment composition is typically an aqueous solution. Said gold-providing agent is preferably a gold complex such as Aui(SCN)i usually in the form of an alkali metal (e.g. Na+ or K*) or ammonium salt.
The reagent in the treatment composition may be a reducing agent. Where said gold-providing agent is Aui(SCN)2 the reagent is preferably a quinone, e.g.
hydroquinone (HQ) or naphtohydroquinone (NHQ). However, any other agent which can reduce a gold-containing molecule or complex to obtain gold metal, but because of kinetic limitations (e.g. high activation energy and low pre-exponential t o factor) will do so in a negligible rate in the absence of a nucleation center, yet, in a meaningful rate (namely in a rate that yields observable results in a not too long period of time) when a nucleation center is present, may also be used.
A treatment composition comprising Aui(SCN)i and HQ in an acidic medium is stable, meaning that gold remains as soluble species in solution and neither precipitates as solid metal nor is deposited on solid substrates other than nucleation centers. When the pH of such a treatment composition is below about 6, the treatment composition is particularly stable. Upon contact with a nucleation center gold metal is deposited on sites of the substrate comprising nucleation centers.
2o The rate of deposition of the gold metal may be controlled, for example, by controlling the pH of the treatment composition: increase in pH will increase the rate of gold deposition and a decrease in pH will decrease the deposition rate.
Furthermore, the rate of deposition may also be controlled by a variety of other means, for example: by controlling the flow parameters of the treatment 25 composition (rapid flow prevents poisoning by by-products, such as CN, which can reduce the rate of gold deposition); by adding surface active agents which can either increase or decrease the rate of deposition (for example polyamines, poly acids or polyalcohols and other surface active agents may have the effect of altering the rate of gold deposition). In addition, by the use of various additives, e.g. those 3o noted above, the roughness of the surface of the deposited gold may be changed _5_ _ {such a change may result in a change of color and electrical properties of the deposited gold).
The method of the invention may be used for assaying the presence or concentration of a specific substance at sites on a substrate. Such a method comprises the following steps:
(a) providing conditions allowing formation of nucleation centers on sites containing said substance;
(b) contacting said substrate with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable io such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation centers to form gold metal at said sites;
and t5 (c) detecting gold deposits on said substrate, a gold deposit at a site on the substrate indicating presence of said substance at said site.
The assay method may be applicable, for example, in a variety of assay techniques, e.g. in techniques involving visualization of specimens in microscopy (which may be an optical or an electron microscope) or any SPM ( ___ ) 2o technique, or in identifying specific separation products on a substrate (for example, a separation product of electrophoresis or chromatography contained in a gel or on a solid substrate such as DNA-chip). In such an assay, the nucleation centers may be formed by the use of said nucleation center-forming agents where the moiety with the specific binding affinity is one member of a recognition group, 25 which may be any of those mentioned above, and the agent to be assayed is another member of the group.
In accordance with another embodiment, the gold deposition method of the invention is used in an assay intended to detect the presence of an analyte in a sample. In particular, the present invention is applicable to such a method where a 3o capturing agent held on a substrate is used to detect the presence of an analyte in a sample that binds specifically to the capturing agent. Such a capturing agent may be a member of a recognition group, while the analyte is another member of the group.
A specific example is the case of assaying for the presence of a target oligonucleotide in a sample, with the capturing agent being an oligonucleotide with a sequence complementary thereto. A nucleation center forming moiety may be bound to analytes presence in the sample, e.g. to the oligonucleotides in the sample, and then after allowing the sample to react with the substrate, and performing a gold deposition reaction as described above, formation of gold deposits will indicate the presence of the analyte in the sample.
to A method of the invention of preparing a specimen for imaging in a microscope, comprises the following steps:
(a) providing conditions permitting formation of nucleation centers at selective sites of the specimen; and (b) contacting said specimen with a treatment composition comprising is said gold-providing agent and a reagent, the composition being kinetically stable such that gold is essentially not deposited on the specimen unless a nucleation center is present thereon, whereby gold atoms from said gold-providing agent are released and deposited onto said specimen at said selective sites.
A method of the invention for detecting the presence of an analyte in a 2o sample, comprises the following steps:
(a) treating the sample to bind nucleation center forming moieties to the analyte, if present in the sample;
(b) reacting the sample with a substrate, holding capturing agents that specifically bind said analyte, and removing unbound sample portions;
2s (c) contacting said substrate with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing - 7._ agent and deposited onto said nucleation centers to form gold metal at said sites;
and (d) detecting gold deposits on said substrate, a gold deposit indicating presence of the analyte in the sample.
A specific application of this method is in the oligonucleotide chips.
Oligonucleotide chips have different capturing oligonucleotides deposited in different sites on the chip. Applying the above method may allow to simultaneously assay for a large number of different oligonucleotides in a sample.
In a so prepared specimen, said selective sites thus contain gold deposits to which permit their visualization. Said selective sites may typically be sites containing a specific substance and the nucleation centers are then formed at said sites by nucleation center forming agents with a moiety having specific binding affinity to said specific substance. In this manner, for example, specific cells, organelles, regions rich with a specific substance, etc. can be clearly visualized.
is A method according to the invention for identifying locations of a specific separation product on a substrate, comprises the following steps:
{a) providing conditions permitting formation of nucleation centers at sites on said substrate comprising said specific separation product;
(b) contacting said substrate with a treatment composition comprising 2o said gold-providing agent and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only where a nucleation center is present thereon, whereby upon such contact, gold atoms from said gold-providing agent are released and deposited onto said nucleation center to form gold metal; and 2s {c) detecting presence of gold on said substrate, such gold signifying presence of said specific separation product on the substrate at a site where the gold is detected.
In a separation technique where the sample is separated into various fractions based on different movement rates of different substances through a 3o medium (typically a gel or a solid) under applied conditions, for example _8_ electrophoresis, thin layer chromatography (TLC), etc., the nucleation centers-forming agents may be admixed to the sample prior to separation. This is usually preferred. For one such prior addition of the nucleation center-forming agent may be more economical, as less material may be required. In addition, where s such agents are applied to the substrate after the separation, they have to diffuse through the medium in order to reach the separated substance located within the medium; such diffusion may be a limiting factor in proper gold-staining of separated fractions. However as will readily be appreciated, it is possible at times to add the nucleation center-forming agent also after separation.
to The present invention also provides a method for assaying presence of an analyte in a sample. Such a method comprises the following steps:
(a) providing a substrate carrying capturing agents which bind said analyte;
(b) contacting said substrate with said sample, whereby said analyte is binds to said capturing agents;
(c) providing conditions permitting formation of nucleation centers on sites of said substrate comprising said analyte;
(d) contacting said substrate with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable 2o such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers; and (e) detecting metallic gold deposits on said substrate, indicative of the presence of said analyte in said sample.
The detection in step (e) of the method for assaying presence of an analyte in 2s a sample, may be carried out by testing appearance of gold deposited on the substrate (gold deposited, depending on size and roughness, may have a color ranging from yellow to orange to red).
In accordance with one embodiment of the invention, the detection in step (e) is based on the electric conductivity of the deposited gold. In this 3o embodiment the capturing agents may be carried on the substrate between electrodes or may be carried on one or more electrodes such that the gold deposited onto the nucleation center in step (d) establishes an electric contact between electrodes. The detection of the gold deposits in step (e) is thus carried out by determining existence of electrical contact between the electrodes, e.g. by measuring the current-potential relationship between the electrodes. The magnitude of the current-potential relationship may be used as a gauge for the agent's concentration in the sample. Alternatively, determining the number of connections in a large array of similar electrode couples with identical capturing agents carried between or on them, may also provide a quantitative measure of the analyte i o concentration.
The assayed ana.lyte may be a member of any of the recognition couples mentioned above, with the other member of the couple being then included as a moiety in the capturing agent. The formation of the nucleation centers in step (c) may be the provision of agents having a binding moiety with specific binding is affinity to the analyte captured on the substrate by the capturing agent, bound to a nucleation-forming moiety, which may be a metal particle, a cluster containing metal atoms or a metal-containing complex, or any other species having the catalytic properties of transforming gold-containing molecular species into gold metal. For example, where the ana.lyte is one member of a binding couple, the 2o binding moiety may be another member (e.g. where the analyte is an antigen, the nucleation center- forming agent may comprise an antibody, which may be the same or different as an antibody used as the capturing agent). The present invention further provides a kit for use in the above method. Such a kit typically comprises a treatment composition. In addition, such a kit may also comprise a reagent for 25 forming nucleation centers at specific sites on a substrate, e.g. such having a specific binding moiety being a member of any of the above binding couples. In addition, a kit for use in the above assay method may also comprise, according to some embodiments, a reagent system for tagging an analyte in a sample with nucleation center-forming moiety. Furthermore, in accordance with some embodiments of the invention, the kit may comprise a substrate comprising electrodes with capturing agents disposed between and/or on the electrodes.
In order to understand the invention and to see how it may be carried out in practice, a preferred embodiment will now be described, by way of non-limiting s example only, with occasional reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows reaction schemes of the manner of preparation of a treatment composition in accordance with an embodiment of the invention (Scheme (a) and Scheme (b)) and of gold deposition onto a nucleation center (Scheme (c)).
to Fig. 2 is a schematic representation of an assay of an analyte in a sample in accordance with an embodiment of the invention.
Fig. 3 is a schematic representation of an assay in accordance with another embodiment of the invention.
Fig. 4 is a schematic representation of an assay in accordance with a further ~ s embodiment of the invention.
Fig. 5 is a schematic illustration of the manner of enhancing specific bands on a solid or a gel substrate, separated by chromatography or by electrophoresis.
Fig. 6 is a schematic illustration of a method in accordance with an embodiment of the invention for imaging specific parts of a microscope specimen.
2o Fig. 7 shows the application of the system in the detection of analytes, oligonucleotides with a specific sequence in this specific example, in a sample.
DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
Preparation of a treatment composition and general gold deposition scheme A treatment composition in accordance with the preferred embodiment of the invention comprises a gold-containing complex- AuISCN. In order to prepare such a treatment composition at a first stage a solution comprising KAumCl4 and KSCN is prepared, typically by mixing two stock solutions, one comprising the gold containing complex and the other the KSCN. For example, such a solution may be formed by mixing equal volumes of a first solution comprising about 0.5 M KSCN and a second solution comprising about 0.05 M KAu~Cl4. Such mixing results in the formation of the complex KAui~t(SCN)4 (See Scheme (a) in Fig.
1).
This complex precipitates but spontaneously forms the complex KAuI(SCN)2.
Typically, after the KAu~(SCN)4 is precipitated, it is washed and resuspended in water or buffer and allowed to undergo the spontaneous reaction (SPONT.) noted above (illustrated in Scheme (b) of Fig. 1).
The KAuI(SCN)2 solution is then mixed with a reducing agent, e.g. with to about 0.055 M hydroquinone (HQ). The reduction of the gold-containing complex by the hydroquinone is then thermodynamically favorable, but owing to the large activation energy and low pre-exponential factor, the kinetics is very slow. At a pH of less than about 6, the spontaneous reduction is practically nil.
Thus, the solution is stable and gold metal is not deposited spontaneously.
is However, as shown in Fig. 1, scheme (c), upon exposure to nucleation centers (NC), acting as catalysts, which may for example be gold colloids, other metal colloids, clusters of metal atoms, metal-containing complexes, metal ions, etc., gold metal (Au°°) is being deposited on the surface of the nucleation center associated with the formation of benzoquinone (BQ).
2o The pH level controls the rate of gold deposition: acidification of the solution, namely lowering pH, slows the metal deposition, while addition of a base, namely increasing pH, accelerates the rate of metal deposition.
It should be noted that under basic pH, some spontaneous deposition of gold may take place even without nucleation centers.
2s Various additives which may either be added initially to the treatment solution, or added during the deposition process, may influence the rate of the gold deposition process and the pattern of the gold deposit (size of deposits, surface roughness, color, etc.). For example, addition of halogen ions to the treatment composition results in surface poisoning of the growing metal centers.
3o This will reduce the rate, and eventually stop the gold deposition process.
Use of such additives thus allows a control of the deposited gold crystalinity, grain size, the rate of the gold deposition, the roughness of the surface of the deposited gold, the electrical properties, etc. The gold deposition process may obviously also be controlled by the change of various other parameters such as temperature, oxygen content, light flux, solution-agitation rate, etc.
The gold deposition process of the invention can be used for a variety of diverse applications, some examples of which will be illustrated below.
Detection of analytes in a sample to An assay in accordance with one embodiment of the invention is illustrated in Fig. 2. Provided by this embodiment is a device 20 having a non conductive substrate 22 carrying electrically conductive electrodes 23. In the gap between electrodes the substrate 22 carries capturing agents 24 which have a specific binding affinity to analyte 26 to be assayed.
is Sample S, which comprises analyte 26, is pretreated by adding nucleation centers 28 and treating it in a manner so that nucleation centers will become coupled to the analyte in a covalent or non covalent interaction, to yield modified analyte 30. In the case of an oligonucleotide analyte, such coupling may, for example, be performed by heating the sample in the presence of a 2o cis-platinum-biotin and then adding an appropriately derivatized cluster, e.g.
Auss(Ph3P)12C16-streptavidin cluster. The cis-platinum-biotin binds to the oligonucleotides, then Auss(Ph3P)12C16- streptavidin binds to the biotin moieties on said nucleotides, thus binding nucleation moieties to the analyte. In the case of a non-nucleotide analyte, coupling may be achieved, for example by binding 2s amino-derivatized cluster or colloid to carboxy moieties of the analyte;
coupling carboxy-derivatized clusters or colloids to amino-moieties of the analyte;
coupling maleimido-derivatized cluster or colloids to thiol moieties of the analyte; etc. As will be appreciated, other substances in a sample may also become tagged with the nucleation center in this process. However, these will not bind to capturing agents 24 and the nucleation centers coupled thereto will thus not remain on the substrate after treatment. (See description below).
Upon contact with device 20, modified analyte 30 binds to the capturing agents to yield nucleation center-forming complexes 32 which are immobilized on substrate 22. Washing the substrate removes unbound substances (NB).
Device 20 may then be contacted with the treatment solution 34 which comprises a gold containing complex such as KAui(SCN)2 and a reducing agent such as hydroquinone (HQ) and consequently upon contact with the nucleation centers 28, gold is deposited on the nucleation centers and forms a continuous o gold mass 36 extending between electrodes 23. In order to avoid that electrodes 23 will act as nucleation centers, they rnay either be made of a conductive material lacking catalytic properties, e.g. silicon passivated with silica, with long alkyl chains, or passivated by coating with an inert material, or, where the electrodes are made of a metal, they may be pretreated to render them is inert as gold-deposition catalysts, e.g. by incubation with a solution comprising a long chain alkane thiol, such as 1-octadecyl-thiol.
By measuring current voltage relationships using a measurement device 40, the existence of an electric contact between the electrodes 23 can be determined, the presence of which indicates the presence of the analyte in the 2o assayed sample.
As can generally be appreciated by the artisan, the binding of the capturing agents to the substrate may be achieved in a number of ways. For example, oxide surfaces may be derivatized with a silicon reagent such as (CH3CH20)3Si-R-X, wherein R may be an alkyl, aryl or other spacer and X may be an active moiety 2s for subsequent binding to a moiety Y in the capturing agent. The nature of X and Y depends on the couple and may be selected from couples consisting of acid and amine, hydroxy and acid, cycloaddition reactions, radical reactions, nucleophilic substitutions, non- covalent interactions, etc., as is well known and clear to the artisan. Where the substance is made of a polymeric material, binding, by any of the above type of reactions, or others, may also be achieved between the capturing agent and a side group of the polymeric material.
Device 20 may comprise two or more electrodes, typically a plurality of electrodes arranged in an array. The array may assume different geometries.
The same capturing agents may be carried between different pairs of electrodes, and/or different capturing agents may be deposited between different electrodes.
A device of the latter kind may be used in the multiplexing assay for simultaneous determination of a number of analytes. In addition, where the same capturing agents are carried between different pairs of electrodes, this may allow io to perform a quantitative assay of concentration of the analyte: for example, the concentration may be assessed based on the number of electric contacts formed between different pairs of electrodes - a large number of electric contacts signifying a large concentration and a small number corresponding to a small concentration.
~5 The electrode array may also be part of a more complex electronic setup containing different components, e.g. diodes, transistors, conductors, capacitors, etc.
Another embodiment of an assay in accordance with the invention can be seen in Fig. 3. The main difference in the case of the embodiment of Fig. 3 from 2o that described in Fig. 2, is that rather than treating sample S to bind nucleation centers 28 to analytes 26 to obtain a modified analyte 30, in the case of the embodiment of Fig. 3, a nucleation center-forming agent I50 is provided. Other components of this assay are very similar to those of Fig. 2 and thus the same reference numeral shifted by one hundred (namely with a "1" prefix) to those 25 used in Fig. 2 were employed in Fig. 3 to indicate like components.
After contact of a device 120 with a sample, analyte 126 binds to a capturing agent 124 and then after washing free (non bound (NB)) analyte molecules and other substances in the sample, the device is contacted with a nucleation center-forming agent 150 which comprises a moiety 152 with a 3o specific binding affinity to analyte 126 which is now bound to capturing agents 124, coupled to a nucleation center 154. Thus, an immobilized nucleation center 132 forms on the substrate in the gap between electrodes 123. Then, after removal of non bound agents 150 (NB) and adding a treatment composition 134 the gold mass 136 forms which provides electric contact between electrodes 123, which may then be determined similarly as shown in Fig. 2.
A further embodiment of an assay in accordance with the invention is seen Fig. 4. In Fig. 4, like elements to those of Figs. 2 and 3 have been marked with the same reference numeral to that used in Fig. 2 shifted by one hundred (namely with a "2" prefix). Sample S containing analyte 226 is reacted with biotin 227 to to yield a treated sample S' with analyte-biotin complexes 231. These are then contacted with substrate 222 which contain capturing agents 224 fitted between electrodes 223, to yield modified capturing complexes 233 on substrate 222.
Gold colloid particles 240 are reacted with an avidin or streptavidin 242 to yield nucleation center forming agents 243. Contacting agent 243 with modified substrate 222 then yields immobilized nucleation centers 235. The subject can then be contacted with a treatment solution 234 similarly as in Figs. 2 and 3 resulting in gold deposition to form a continuous gold mass 236 between electrodes 223.
As will no doubt be appreciated by the artisan, various modifications of .the embodiments shown above are possible.
Visualization of separation products The method of the invention can be used for visualizing separation product obtained in a number of separation techniques such as gel electrophoresis, gel 2s permeation techniques, size exclusion chromatography, affinity chromatography and others. This is illustrated schematically in Fig. 5.
Substrate 200, which may be a gel or a solid substrate containing different lanes 202, each consisting of a plurality of bands 204, each one being a specific fraction of a sample separated in each lane. Such a substrate 200 may be obtained 3o by any of the techniques noted above.
In order to visualize the existence of a specific substance and locate its band. a nucleation center-forming agent 206 which has a moiety 208 which specifically binds to the substance in a nucleation center 210 is contacted with substrate 200 and after access, agents 206 are washed away, the substrate is s contacted with a treatment solution 212 and consequently gold deposits 214 will form on bands containing that substance (the other bands are not visible and are included only for illustration purposes). Preferably, however, nucleation center-forming agents 206 may be added to the substrate prior to the beginning of the separation process since diffusion of subsequently-added nucleation to center-forming agents may be a limiting factor to achieve binding of these agents to the separated substance.
Depending on the exact deposition conditions, which will inter alia determine the roughness of the surfaces of the deposited gold mass, the color of the bands may vary between yellow to black. Using various visualization is techniques, based on measurement of light absorbance or transmission through the bands, a quantitative measurement of a separate substance may be obtained.
In the alternative, rather than optical techniques, the gold deposits may also be detected by various electric detection techniques. This may be achieved for example by providing two planar arrays of electrodes sandwiching the 2o separation matrix which will permit an automatic electric detection.
Contrast enhancing in imaging techniques There are many imaging techniques which request contrasting agents in order to view certain components. Such is the case in optical microscopy, 2s electron microscopy (transmission electron microscopy, scanning electron microscopy) as well as in other imaging techniques, such as atomic force microscopy. Hitherto, such imaging techniques involved silver metal deposition or carbon deposition and some others.
In the case of biological specimens, contrast enhancers are required to 3o allow visualization of specific tissues, cells, organelles, etc.
In accordance with the invention, as illustrated in Fig. 6, a biological specimen 300, containing a cell 302 with a non visible organelle 304, is treated in accordance with the invention by successive exposure to nucleation center-forming agent 306 which has a binding moiety 308 specific to substance included in organelle 304 and a nucleation center 314 and after treatment with a treatment composition 312, organelle 304 is visible as a dark or opaque deposit 314.
Imaging of oligonucleotide hybridization to The assaying of the presence and concentration of specific-sequence oligonucleotides is nowadays typically being performed by the use of oligonucleotide probes of a complementary sequence attached to known locations on a substrate. Specific and widely used examples of such systems are the so-called DNA-chips. Such chips are surfaces bearing a plurality of i s oligonicleotide-probe sequences in known and discreet locations on a surface. A
sample that may or may not contain the target sequences that complement the probe sequences on chip is treated so that all DNA fragments are labeled (usually by fluorescent labels). Contacting the sample with the surface of the chip under appropriate conditions, the target oligonucleotides attach to the surface in 20 locations bearing the complementary sequence. Detection of hybridization products is usually done by following the fluorescence of labeled duplexes.
The location of hybridization product indicates the sequence of the probe and fluorescence intensity indicates their surface concentration.
Reference is now being made to Fig. 7 showing the application of the gold 25 deposition method of the invention in visualization of hybridization products on a DNA-chip using different possible visualization techniques such as optical techniques (absorption, reflectance) and non optical visualization techniques (AMF, STM etc.). As no doubt will be appreciated, this is but an example to the use of the method of the invention for visualizing binding of targets to probes in general, e.g. binding of c-DNA strands to complementary strands, a binding of an antibody to an antigen and other types of recognition couples.
A DNA-chip substrate 400 carries a plurality of DNA probe sites, three 402, 404 and 406 being exemplified, each one having a different nucleotide sequence. A sample S that may contain the target oligonucleotides 410 is treated in a way that all DNA species in solution become labeled by label 412, thus obtaining modified sample S' that may contain modified analyte (if analyte was present in S). Contacting modified sample S' with DNA-chip substrate 400 under appropriate conditions allows selective hybridization of DNA probes on chip to to target oligonucleotides if present in modified sample S'. After washing the chip, nucleation centers-forming agents 430 are introduced to the system under condition allowing their binding to labels 412 on labeled oligonucleotides if present at the different sites on chip. After washing, nucleation centers are present only at locations where hybridization between probes on chip and target s from solution occurred. Visualization of hybridization is achieved by applying the gold deposition method of the invention, thus growing gold grains from the nucleation centers on-chip and detecting the gold 440 grains using different techniques such as optical techniques and SPM techniques (AFM, STM etc.).
In another embodiment, the label serves itself as a nucleation center. In 2o such case, the step of attaching the nucleation center to the label is skipped.
FIELD OF THE INVENTION
The invention relates to chemical deposition of gold metal on substrates.
BACKGROUND OF THE INVENTION
There are various techniques and uses in which metal substances are deposited on substrates. In various such methods, the metal to be deposited is provided in a form of a soluble complex or molecule, e.g. in an aqueous solution.
Under appropriate conditions the complex or molecule is reduced and deposits the metal onto the substrate.
At times, in order to ensure deposition of metal from solution onto a io substrate, it is preferable to first provide nucleation centers on the substrate. Such nucleation centers may, for example, be a variety of metal complexes, clusters or small metal particles, deposited on or attached to the surface.
Examples of techniques involving metal deposition are a variety of image formation or latent image contrast-enhancement techniques for photography, 15 optical microscopy or electron microscopy. Another example of laboratory techniques where metal complexes are deposited onto a substrate, is in imaging of separation products, e.g. proteins or nucleic acids, in a variety of chromatographic or electrophoretic techniques.
The metal most typically used in such techniques is silver. However, one 2o typical drawback of silver deposition is that the deposition is not completely specific and some degree of spontaneous deposition of silver may occur also without an a priori deposition of nucleation centers. Thus, where silver deposition is used in image-enhancement or contrast-enhancement methods, there is typically a limited signal-to-noise ratio.
_2_ GENERAL DESCRIPTION OF THE INVENTION
The present invention has, as one of its objects, the provision of a method for depositing gold onto specific sites on a substrate. Another object of the invention is to provide a composition and kit for use in such a method.
In accordance with the present invention gold, initially contained in a soluble gold-providing agent, being a gold-containing molecule, cluster or complex, is deposited onto nucleation centers. The term "nucleation centers "
as used herein refers to any salt, complex, cluster or particle having catalytic properties of transforming gold from a gold-containing molecule or complex into io gold metal. Particles with a metal surface are, for example, colloid metal particles, a variety of metal complexes, clusters containing metal atoms, etc.
In accordance with the invention there is provided a method for depositing gold at one or more sites on a substrate, comprising:
(a) binding, depositing or forming nucleation centers at said one or more 1 s sites;
(b) contacting said one or more sites with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable such that gold metal is essentially not deposited on the substrate unless a nucleation center is present on the substrate and in the presence of a 2o nucleation center at said one or more sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said one or more sites.
As will be appreciated, once gold is deposited on the substrate, it serves as a nucleation center for further gold deposition. By appropriately controlling the 2s incubation time as well as other conditions affecting the gold deposition (some of which will be outlined bellow), the amount of the deposited gold at a deposition site can be controlled. Furthermore, although the initial gold deposition may be at discrete sites on the substrate, by allowing the gold deposits to grow, following further deposition, discrete sites may combine to form one larger gold deposit 3o encompassing the so combined sites.
_3_ The term "essentially not deposited " means to denote that there is either no gold separation from the solution and the gold atoms remain within the soluble molecule or complex, or that gold metal deposition on a substrate is negligible and thus not or only hardly observable and measurable, yielding a high signal-to-noise s ratio.
In accordance with one embodiment, the nucleation centers are formed by chemical or physical deposition of nucleation center forming agent onto the one or more sites. By another embodiment, such nucleation centers may be formed chemically at said one or more sites by a redox reaction in which metal ions, in io particular silver ions, are oxidized into metallic silver. Such chemical formation of nucleation centers is known per se (see for example WO 99/04402 and PCT/IL99/00232).
In accordance with yet another embodiment, the nucleation centers are formed by binding of nucleation center-forming agents at said one or more sites.
is Such agents comprise at least one binding moiety with a binding affinity (which may be specific or non-specific) to said one or more sites, which is bound to at least one nucleation center moiety. The nucleation center moiety is a species that can act as a catalytic agent for gold metal deposition, e.g. a salt, metal particle, cluster of metal atoms or a metal-containing complex. The binding moiety may, for example, 2o be one member of a recognition group, where another member of the recognition group forms or is included in said one or more sites. The recognition group, typically a recognition couple, consists of two or more substances with a binding affinity one to the other. The recognition group may be, but is not limited to, any one of the following couples: an antigen and an antibody or an antibody derivative 25 with a complementary antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or synthetic binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain.
The nucleation center moiety is preferably a gold particle or a cluster ;o containing gold atoms, e.g. Aull or AuSS or Au~4~ (gold clusters that contain 11, 55 or 147 gold atoms, respectively). The treatment composition is typically an aqueous solution. Said gold-providing agent is preferably a gold complex such as Aui(SCN)i usually in the form of an alkali metal (e.g. Na+ or K*) or ammonium salt.
The reagent in the treatment composition may be a reducing agent. Where said gold-providing agent is Aui(SCN)2 the reagent is preferably a quinone, e.g.
hydroquinone (HQ) or naphtohydroquinone (NHQ). However, any other agent which can reduce a gold-containing molecule or complex to obtain gold metal, but because of kinetic limitations (e.g. high activation energy and low pre-exponential t o factor) will do so in a negligible rate in the absence of a nucleation center, yet, in a meaningful rate (namely in a rate that yields observable results in a not too long period of time) when a nucleation center is present, may also be used.
A treatment composition comprising Aui(SCN)i and HQ in an acidic medium is stable, meaning that gold remains as soluble species in solution and neither precipitates as solid metal nor is deposited on solid substrates other than nucleation centers. When the pH of such a treatment composition is below about 6, the treatment composition is particularly stable. Upon contact with a nucleation center gold metal is deposited on sites of the substrate comprising nucleation centers.
2o The rate of deposition of the gold metal may be controlled, for example, by controlling the pH of the treatment composition: increase in pH will increase the rate of gold deposition and a decrease in pH will decrease the deposition rate.
Furthermore, the rate of deposition may also be controlled by a variety of other means, for example: by controlling the flow parameters of the treatment 25 composition (rapid flow prevents poisoning by by-products, such as CN, which can reduce the rate of gold deposition); by adding surface active agents which can either increase or decrease the rate of deposition (for example polyamines, poly acids or polyalcohols and other surface active agents may have the effect of altering the rate of gold deposition). In addition, by the use of various additives, e.g. those 3o noted above, the roughness of the surface of the deposited gold may be changed _5_ _ {such a change may result in a change of color and electrical properties of the deposited gold).
The method of the invention may be used for assaying the presence or concentration of a specific substance at sites on a substrate. Such a method comprises the following steps:
(a) providing conditions allowing formation of nucleation centers on sites containing said substance;
(b) contacting said substrate with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable io such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation centers to form gold metal at said sites;
and t5 (c) detecting gold deposits on said substrate, a gold deposit at a site on the substrate indicating presence of said substance at said site.
The assay method may be applicable, for example, in a variety of assay techniques, e.g. in techniques involving visualization of specimens in microscopy (which may be an optical or an electron microscope) or any SPM ( ___ ) 2o technique, or in identifying specific separation products on a substrate (for example, a separation product of electrophoresis or chromatography contained in a gel or on a solid substrate such as DNA-chip). In such an assay, the nucleation centers may be formed by the use of said nucleation center-forming agents where the moiety with the specific binding affinity is one member of a recognition group, 25 which may be any of those mentioned above, and the agent to be assayed is another member of the group.
In accordance with another embodiment, the gold deposition method of the invention is used in an assay intended to detect the presence of an analyte in a sample. In particular, the present invention is applicable to such a method where a 3o capturing agent held on a substrate is used to detect the presence of an analyte in a sample that binds specifically to the capturing agent. Such a capturing agent may be a member of a recognition group, while the analyte is another member of the group.
A specific example is the case of assaying for the presence of a target oligonucleotide in a sample, with the capturing agent being an oligonucleotide with a sequence complementary thereto. A nucleation center forming moiety may be bound to analytes presence in the sample, e.g. to the oligonucleotides in the sample, and then after allowing the sample to react with the substrate, and performing a gold deposition reaction as described above, formation of gold deposits will indicate the presence of the analyte in the sample.
to A method of the invention of preparing a specimen for imaging in a microscope, comprises the following steps:
(a) providing conditions permitting formation of nucleation centers at selective sites of the specimen; and (b) contacting said specimen with a treatment composition comprising is said gold-providing agent and a reagent, the composition being kinetically stable such that gold is essentially not deposited on the specimen unless a nucleation center is present thereon, whereby gold atoms from said gold-providing agent are released and deposited onto said specimen at said selective sites.
A method of the invention for detecting the presence of an analyte in a 2o sample, comprises the following steps:
(a) treating the sample to bind nucleation center forming moieties to the analyte, if present in the sample;
(b) reacting the sample with a substrate, holding capturing agents that specifically bind said analyte, and removing unbound sample portions;
2s (c) contacting said substrate with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing - 7._ agent and deposited onto said nucleation centers to form gold metal at said sites;
and (d) detecting gold deposits on said substrate, a gold deposit indicating presence of the analyte in the sample.
A specific application of this method is in the oligonucleotide chips.
Oligonucleotide chips have different capturing oligonucleotides deposited in different sites on the chip. Applying the above method may allow to simultaneously assay for a large number of different oligonucleotides in a sample.
In a so prepared specimen, said selective sites thus contain gold deposits to which permit their visualization. Said selective sites may typically be sites containing a specific substance and the nucleation centers are then formed at said sites by nucleation center forming agents with a moiety having specific binding affinity to said specific substance. In this manner, for example, specific cells, organelles, regions rich with a specific substance, etc. can be clearly visualized.
is A method according to the invention for identifying locations of a specific separation product on a substrate, comprises the following steps:
{a) providing conditions permitting formation of nucleation centers at sites on said substrate comprising said specific separation product;
(b) contacting said substrate with a treatment composition comprising 2o said gold-providing agent and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only where a nucleation center is present thereon, whereby upon such contact, gold atoms from said gold-providing agent are released and deposited onto said nucleation center to form gold metal; and 2s {c) detecting presence of gold on said substrate, such gold signifying presence of said specific separation product on the substrate at a site where the gold is detected.
In a separation technique where the sample is separated into various fractions based on different movement rates of different substances through a 3o medium (typically a gel or a solid) under applied conditions, for example _8_ electrophoresis, thin layer chromatography (TLC), etc., the nucleation centers-forming agents may be admixed to the sample prior to separation. This is usually preferred. For one such prior addition of the nucleation center-forming agent may be more economical, as less material may be required. In addition, where s such agents are applied to the substrate after the separation, they have to diffuse through the medium in order to reach the separated substance located within the medium; such diffusion may be a limiting factor in proper gold-staining of separated fractions. However as will readily be appreciated, it is possible at times to add the nucleation center-forming agent also after separation.
to The present invention also provides a method for assaying presence of an analyte in a sample. Such a method comprises the following steps:
(a) providing a substrate carrying capturing agents which bind said analyte;
(b) contacting said substrate with said sample, whereby said analyte is binds to said capturing agents;
(c) providing conditions permitting formation of nucleation centers on sites of said substrate comprising said analyte;
(d) contacting said substrate with a treatment composition comprising said gold-providing agent and a reagent, the composition being kinetically stable 2o such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers; and (e) detecting metallic gold deposits on said substrate, indicative of the presence of said analyte in said sample.
The detection in step (e) of the method for assaying presence of an analyte in 2s a sample, may be carried out by testing appearance of gold deposited on the substrate (gold deposited, depending on size and roughness, may have a color ranging from yellow to orange to red).
In accordance with one embodiment of the invention, the detection in step (e) is based on the electric conductivity of the deposited gold. In this 3o embodiment the capturing agents may be carried on the substrate between electrodes or may be carried on one or more electrodes such that the gold deposited onto the nucleation center in step (d) establishes an electric contact between electrodes. The detection of the gold deposits in step (e) is thus carried out by determining existence of electrical contact between the electrodes, e.g. by measuring the current-potential relationship between the electrodes. The magnitude of the current-potential relationship may be used as a gauge for the agent's concentration in the sample. Alternatively, determining the number of connections in a large array of similar electrode couples with identical capturing agents carried between or on them, may also provide a quantitative measure of the analyte i o concentration.
The assayed ana.lyte may be a member of any of the recognition couples mentioned above, with the other member of the couple being then included as a moiety in the capturing agent. The formation of the nucleation centers in step (c) may be the provision of agents having a binding moiety with specific binding is affinity to the analyte captured on the substrate by the capturing agent, bound to a nucleation-forming moiety, which may be a metal particle, a cluster containing metal atoms or a metal-containing complex, or any other species having the catalytic properties of transforming gold-containing molecular species into gold metal. For example, where the ana.lyte is one member of a binding couple, the 2o binding moiety may be another member (e.g. where the analyte is an antigen, the nucleation center- forming agent may comprise an antibody, which may be the same or different as an antibody used as the capturing agent). The present invention further provides a kit for use in the above method. Such a kit typically comprises a treatment composition. In addition, such a kit may also comprise a reagent for 25 forming nucleation centers at specific sites on a substrate, e.g. such having a specific binding moiety being a member of any of the above binding couples. In addition, a kit for use in the above assay method may also comprise, according to some embodiments, a reagent system for tagging an analyte in a sample with nucleation center-forming moiety. Furthermore, in accordance with some embodiments of the invention, the kit may comprise a substrate comprising electrodes with capturing agents disposed between and/or on the electrodes.
In order to understand the invention and to see how it may be carried out in practice, a preferred embodiment will now be described, by way of non-limiting s example only, with occasional reference to the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows reaction schemes of the manner of preparation of a treatment composition in accordance with an embodiment of the invention (Scheme (a) and Scheme (b)) and of gold deposition onto a nucleation center (Scheme (c)).
to Fig. 2 is a schematic representation of an assay of an analyte in a sample in accordance with an embodiment of the invention.
Fig. 3 is a schematic representation of an assay in accordance with another embodiment of the invention.
Fig. 4 is a schematic representation of an assay in accordance with a further ~ s embodiment of the invention.
Fig. 5 is a schematic illustration of the manner of enhancing specific bands on a solid or a gel substrate, separated by chromatography or by electrophoresis.
Fig. 6 is a schematic illustration of a method in accordance with an embodiment of the invention for imaging specific parts of a microscope specimen.
2o Fig. 7 shows the application of the system in the detection of analytes, oligonucleotides with a specific sequence in this specific example, in a sample.
DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
Preparation of a treatment composition and general gold deposition scheme A treatment composition in accordance with the preferred embodiment of the invention comprises a gold-containing complex- AuISCN. In order to prepare such a treatment composition at a first stage a solution comprising KAumCl4 and KSCN is prepared, typically by mixing two stock solutions, one comprising the gold containing complex and the other the KSCN. For example, such a solution may be formed by mixing equal volumes of a first solution comprising about 0.5 M KSCN and a second solution comprising about 0.05 M KAu~Cl4. Such mixing results in the formation of the complex KAui~t(SCN)4 (See Scheme (a) in Fig.
1).
This complex precipitates but spontaneously forms the complex KAuI(SCN)2.
Typically, after the KAu~(SCN)4 is precipitated, it is washed and resuspended in water or buffer and allowed to undergo the spontaneous reaction (SPONT.) noted above (illustrated in Scheme (b) of Fig. 1).
The KAuI(SCN)2 solution is then mixed with a reducing agent, e.g. with to about 0.055 M hydroquinone (HQ). The reduction of the gold-containing complex by the hydroquinone is then thermodynamically favorable, but owing to the large activation energy and low pre-exponential factor, the kinetics is very slow. At a pH of less than about 6, the spontaneous reduction is practically nil.
Thus, the solution is stable and gold metal is not deposited spontaneously.
is However, as shown in Fig. 1, scheme (c), upon exposure to nucleation centers (NC), acting as catalysts, which may for example be gold colloids, other metal colloids, clusters of metal atoms, metal-containing complexes, metal ions, etc., gold metal (Au°°) is being deposited on the surface of the nucleation center associated with the formation of benzoquinone (BQ).
2o The pH level controls the rate of gold deposition: acidification of the solution, namely lowering pH, slows the metal deposition, while addition of a base, namely increasing pH, accelerates the rate of metal deposition.
It should be noted that under basic pH, some spontaneous deposition of gold may take place even without nucleation centers.
2s Various additives which may either be added initially to the treatment solution, or added during the deposition process, may influence the rate of the gold deposition process and the pattern of the gold deposit (size of deposits, surface roughness, color, etc.). For example, addition of halogen ions to the treatment composition results in surface poisoning of the growing metal centers.
3o This will reduce the rate, and eventually stop the gold deposition process.
Use of such additives thus allows a control of the deposited gold crystalinity, grain size, the rate of the gold deposition, the roughness of the surface of the deposited gold, the electrical properties, etc. The gold deposition process may obviously also be controlled by the change of various other parameters such as temperature, oxygen content, light flux, solution-agitation rate, etc.
The gold deposition process of the invention can be used for a variety of diverse applications, some examples of which will be illustrated below.
Detection of analytes in a sample to An assay in accordance with one embodiment of the invention is illustrated in Fig. 2. Provided by this embodiment is a device 20 having a non conductive substrate 22 carrying electrically conductive electrodes 23. In the gap between electrodes the substrate 22 carries capturing agents 24 which have a specific binding affinity to analyte 26 to be assayed.
is Sample S, which comprises analyte 26, is pretreated by adding nucleation centers 28 and treating it in a manner so that nucleation centers will become coupled to the analyte in a covalent or non covalent interaction, to yield modified analyte 30. In the case of an oligonucleotide analyte, such coupling may, for example, be performed by heating the sample in the presence of a 2o cis-platinum-biotin and then adding an appropriately derivatized cluster, e.g.
Auss(Ph3P)12C16-streptavidin cluster. The cis-platinum-biotin binds to the oligonucleotides, then Auss(Ph3P)12C16- streptavidin binds to the biotin moieties on said nucleotides, thus binding nucleation moieties to the analyte. In the case of a non-nucleotide analyte, coupling may be achieved, for example by binding 2s amino-derivatized cluster or colloid to carboxy moieties of the analyte;
coupling carboxy-derivatized clusters or colloids to amino-moieties of the analyte;
coupling maleimido-derivatized cluster or colloids to thiol moieties of the analyte; etc. As will be appreciated, other substances in a sample may also become tagged with the nucleation center in this process. However, these will not bind to capturing agents 24 and the nucleation centers coupled thereto will thus not remain on the substrate after treatment. (See description below).
Upon contact with device 20, modified analyte 30 binds to the capturing agents to yield nucleation center-forming complexes 32 which are immobilized on substrate 22. Washing the substrate removes unbound substances (NB).
Device 20 may then be contacted with the treatment solution 34 which comprises a gold containing complex such as KAui(SCN)2 and a reducing agent such as hydroquinone (HQ) and consequently upon contact with the nucleation centers 28, gold is deposited on the nucleation centers and forms a continuous o gold mass 36 extending between electrodes 23. In order to avoid that electrodes 23 will act as nucleation centers, they rnay either be made of a conductive material lacking catalytic properties, e.g. silicon passivated with silica, with long alkyl chains, or passivated by coating with an inert material, or, where the electrodes are made of a metal, they may be pretreated to render them is inert as gold-deposition catalysts, e.g. by incubation with a solution comprising a long chain alkane thiol, such as 1-octadecyl-thiol.
By measuring current voltage relationships using a measurement device 40, the existence of an electric contact between the electrodes 23 can be determined, the presence of which indicates the presence of the analyte in the 2o assayed sample.
As can generally be appreciated by the artisan, the binding of the capturing agents to the substrate may be achieved in a number of ways. For example, oxide surfaces may be derivatized with a silicon reagent such as (CH3CH20)3Si-R-X, wherein R may be an alkyl, aryl or other spacer and X may be an active moiety 2s for subsequent binding to a moiety Y in the capturing agent. The nature of X and Y depends on the couple and may be selected from couples consisting of acid and amine, hydroxy and acid, cycloaddition reactions, radical reactions, nucleophilic substitutions, non- covalent interactions, etc., as is well known and clear to the artisan. Where the substance is made of a polymeric material, binding, by any of the above type of reactions, or others, may also be achieved between the capturing agent and a side group of the polymeric material.
Device 20 may comprise two or more electrodes, typically a plurality of electrodes arranged in an array. The array may assume different geometries.
The same capturing agents may be carried between different pairs of electrodes, and/or different capturing agents may be deposited between different electrodes.
A device of the latter kind may be used in the multiplexing assay for simultaneous determination of a number of analytes. In addition, where the same capturing agents are carried between different pairs of electrodes, this may allow io to perform a quantitative assay of concentration of the analyte: for example, the concentration may be assessed based on the number of electric contacts formed between different pairs of electrodes - a large number of electric contacts signifying a large concentration and a small number corresponding to a small concentration.
~5 The electrode array may also be part of a more complex electronic setup containing different components, e.g. diodes, transistors, conductors, capacitors, etc.
Another embodiment of an assay in accordance with the invention can be seen in Fig. 3. The main difference in the case of the embodiment of Fig. 3 from 2o that described in Fig. 2, is that rather than treating sample S to bind nucleation centers 28 to analytes 26 to obtain a modified analyte 30, in the case of the embodiment of Fig. 3, a nucleation center-forming agent I50 is provided. Other components of this assay are very similar to those of Fig. 2 and thus the same reference numeral shifted by one hundred (namely with a "1" prefix) to those 25 used in Fig. 2 were employed in Fig. 3 to indicate like components.
After contact of a device 120 with a sample, analyte 126 binds to a capturing agent 124 and then after washing free (non bound (NB)) analyte molecules and other substances in the sample, the device is contacted with a nucleation center-forming agent 150 which comprises a moiety 152 with a 3o specific binding affinity to analyte 126 which is now bound to capturing agents 124, coupled to a nucleation center 154. Thus, an immobilized nucleation center 132 forms on the substrate in the gap between electrodes 123. Then, after removal of non bound agents 150 (NB) and adding a treatment composition 134 the gold mass 136 forms which provides electric contact between electrodes 123, which may then be determined similarly as shown in Fig. 2.
A further embodiment of an assay in accordance with the invention is seen Fig. 4. In Fig. 4, like elements to those of Figs. 2 and 3 have been marked with the same reference numeral to that used in Fig. 2 shifted by one hundred (namely with a "2" prefix). Sample S containing analyte 226 is reacted with biotin 227 to to yield a treated sample S' with analyte-biotin complexes 231. These are then contacted with substrate 222 which contain capturing agents 224 fitted between electrodes 223, to yield modified capturing complexes 233 on substrate 222.
Gold colloid particles 240 are reacted with an avidin or streptavidin 242 to yield nucleation center forming agents 243. Contacting agent 243 with modified substrate 222 then yields immobilized nucleation centers 235. The subject can then be contacted with a treatment solution 234 similarly as in Figs. 2 and 3 resulting in gold deposition to form a continuous gold mass 236 between electrodes 223.
As will no doubt be appreciated by the artisan, various modifications of .the embodiments shown above are possible.
Visualization of separation products The method of the invention can be used for visualizing separation product obtained in a number of separation techniques such as gel electrophoresis, gel 2s permeation techniques, size exclusion chromatography, affinity chromatography and others. This is illustrated schematically in Fig. 5.
Substrate 200, which may be a gel or a solid substrate containing different lanes 202, each consisting of a plurality of bands 204, each one being a specific fraction of a sample separated in each lane. Such a substrate 200 may be obtained 3o by any of the techniques noted above.
In order to visualize the existence of a specific substance and locate its band. a nucleation center-forming agent 206 which has a moiety 208 which specifically binds to the substance in a nucleation center 210 is contacted with substrate 200 and after access, agents 206 are washed away, the substrate is s contacted with a treatment solution 212 and consequently gold deposits 214 will form on bands containing that substance (the other bands are not visible and are included only for illustration purposes). Preferably, however, nucleation center-forming agents 206 may be added to the substrate prior to the beginning of the separation process since diffusion of subsequently-added nucleation to center-forming agents may be a limiting factor to achieve binding of these agents to the separated substance.
Depending on the exact deposition conditions, which will inter alia determine the roughness of the surfaces of the deposited gold mass, the color of the bands may vary between yellow to black. Using various visualization is techniques, based on measurement of light absorbance or transmission through the bands, a quantitative measurement of a separate substance may be obtained.
In the alternative, rather than optical techniques, the gold deposits may also be detected by various electric detection techniques. This may be achieved for example by providing two planar arrays of electrodes sandwiching the 2o separation matrix which will permit an automatic electric detection.
Contrast enhancing in imaging techniques There are many imaging techniques which request contrasting agents in order to view certain components. Such is the case in optical microscopy, 2s electron microscopy (transmission electron microscopy, scanning electron microscopy) as well as in other imaging techniques, such as atomic force microscopy. Hitherto, such imaging techniques involved silver metal deposition or carbon deposition and some others.
In the case of biological specimens, contrast enhancers are required to 3o allow visualization of specific tissues, cells, organelles, etc.
In accordance with the invention, as illustrated in Fig. 6, a biological specimen 300, containing a cell 302 with a non visible organelle 304, is treated in accordance with the invention by successive exposure to nucleation center-forming agent 306 which has a binding moiety 308 specific to substance included in organelle 304 and a nucleation center 314 and after treatment with a treatment composition 312, organelle 304 is visible as a dark or opaque deposit 314.
Imaging of oligonucleotide hybridization to The assaying of the presence and concentration of specific-sequence oligonucleotides is nowadays typically being performed by the use of oligonucleotide probes of a complementary sequence attached to known locations on a substrate. Specific and widely used examples of such systems are the so-called DNA-chips. Such chips are surfaces bearing a plurality of i s oligonicleotide-probe sequences in known and discreet locations on a surface. A
sample that may or may not contain the target sequences that complement the probe sequences on chip is treated so that all DNA fragments are labeled (usually by fluorescent labels). Contacting the sample with the surface of the chip under appropriate conditions, the target oligonucleotides attach to the surface in 20 locations bearing the complementary sequence. Detection of hybridization products is usually done by following the fluorescence of labeled duplexes.
The location of hybridization product indicates the sequence of the probe and fluorescence intensity indicates their surface concentration.
Reference is now being made to Fig. 7 showing the application of the gold 25 deposition method of the invention in visualization of hybridization products on a DNA-chip using different possible visualization techniques such as optical techniques (absorption, reflectance) and non optical visualization techniques (AMF, STM etc.). As no doubt will be appreciated, this is but an example to the use of the method of the invention for visualizing binding of targets to probes in general, e.g. binding of c-DNA strands to complementary strands, a binding of an antibody to an antigen and other types of recognition couples.
A DNA-chip substrate 400 carries a plurality of DNA probe sites, three 402, 404 and 406 being exemplified, each one having a different nucleotide sequence. A sample S that may contain the target oligonucleotides 410 is treated in a way that all DNA species in solution become labeled by label 412, thus obtaining modified sample S' that may contain modified analyte (if analyte was present in S). Contacting modified sample S' with DNA-chip substrate 400 under appropriate conditions allows selective hybridization of DNA probes on chip to to target oligonucleotides if present in modified sample S'. After washing the chip, nucleation centers-forming agents 430 are introduced to the system under condition allowing their binding to labels 412 on labeled oligonucleotides if present at the different sites on chip. After washing, nucleation centers are present only at locations where hybridization between probes on chip and target s from solution occurred. Visualization of hybridization is achieved by applying the gold deposition method of the invention, thus growing gold grains from the nucleation centers on-chip and detecting the gold 440 grains using different techniques such as optical techniques and SPM techniques (AFM, STM etc.).
In another embodiment, the label serves itself as a nucleation center. In 2o such case, the step of attaching the nucleation center to the label is skipped.
Claims
CLAIMS:
1. A method for depositing gold at one or more sites on a substrate, comprising:
(a) binding, depositing or forming nucleation centers at said one or more sites; said nucleation centers comprising at least one member of a recognition group consisting of two or more {}molecules or complexes which bind {}to each other, the other member including or forming said one or more sites, coupled to at least one nucleation center being one or mere of the group consisting of metal particle, cluster containing metal atoms, a metal-containing complex and molecules.
(b) Contacting under appropriate conditions said one or more sites with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the substrate unless a nucleation center is present on the substrate and in the presence of a nucleation center at said one or more sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said one or mare sites.
2. A method according to Claim 1, wherein the one member of the recognition group is coupled to at last one nucleation center, being one or more of the group consisting of: cluster containing metal atoms and metal containing complexes and metals.
3. A method according to Claim 1, wherein the one member of the recognition group is coupled to at least one nucleation center being one or more of the group consisting of gold particle, cluster confining gold atoms and gold-containing complexes and molecules.
4. A method according to Claim 1, wherein the one member of the recognition group is coupled to at least one nucleation center being one or more of the group consisting of cluster containing gold atoms and gold-containing complexes and molecules.
5. A method according to Claim 1, wherein said {} recognition group is a member of the group consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent;
biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain.
6. A method according to any one of Claims 1 to 5, wherein said treatment composition is an aqueous solution.
7. A method according to Claim 6, wherein said gold-providing agent is Au1(SCN)2.
8. A method according to Claim 7, wherein said reagent is hydroquinone or naphtohydroqninone.
9. A method for assaying presence of a specific substance at sites on a substrate, comprising:
(a) providing conditions showing formation of nucleation centers on sites containing said substance;
(b) contacting said substrate with a treatment composition comprising a soluble gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited an the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said sites; and (c) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating presence of said substance at said site.
10. A method according to Claim 9, wherein step (a) comprises:
(a1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said substance, bound to at least one nucleation center being one or more of the group consisting of metal particle, cluster containing metal atoms and a metal-containing complex; and (a2) contacting said substrate with said agents.
11. A method according to Claim 10, wherein said moiety is included in one member of a recognition couple consisting of two molecules or complexes which specifically bind to one another, the other member included in or constituting said substance.
12. A method according to Claim 11, wherein said recognition couple is a member of the group consisting of an antigen and as antibody or an antibody derivative with as antigen binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain; said moiety being one of the recognition couple and said substance being or including the other.
13. A method according to any one of Claims 9-12, for assaying the presence of one or more target oligonucleotides with a specific target sequence in a sample, comprising:
(a) providing a substrate carrying one or more probe oligonucleotides each with a probing sequence complementary to one of said target sequences;
(b) contacting said substrate with the sample and providing conditions allowing formation of nucleation centers where a target oligonucleotide hybridizes to a probe oligonucleotide;
(c) contacting said substrate with a treatment composition comprising a gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to forth gold metal deposits at said sites; and (d) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating the presence of said substance at said site.
14. A method according co Claim 13, wherein said step (b) comprises:
(b1) treating said sample to bind a label to oligonucleotides in the sample;
(b2) contacting said sample with said substrate; and (b3) contacting said substrate with a nucleation center-containing agent, capable of specific binding to said label.
15. A method according to Claim 13, wherein said step (b) comprises:
(b1) treating sand sample so as to bind nucleation centers to oligonucleotides present therein, and (b2) contacting said samples with said substrate.
16. A method according to any one of Claims 9 to 15, wherein said nucleation center is a gold particle a cluster containing gold atoms, or a gold-containing complex or molecules.
17. A method according to any one of Claims 9 to 16, wherein said treatment composition is an aqueous solution.
18. A method according so Claim 17, wherein said gold-providing agent is Au1(SCN)2 and said reagent is a quinone.
19. A method according to any one of Claims 9 to 18, wherein said substrate is a specimen for viewing in an imaging or visualization technique.
20. A method according to Claim 19, wherein the detention technique is based on light.
21. A method according to Claim 19, wherein the {} detection technique is based on light absorbance and/or light transmission and/or light reflectance and/or light scattering.
22. A method according to Claim 19, wherein said detection is made by techniques selected from: tansmission electron microscopy, scanning electron microscopy, atomic force microscopy.
23. A method according to Claim 19, for preparing the specimen for viewing in a microscope, comprising the following steps:
(a) providing conditions permitting formation of nucleation centers at selective sites of the specimen; and (b) contacting said specimen with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the specimen a nucleation center is present thereon, whereby gold atoms from said gold-providing agent are released and deposited onto said specimen at selective sites.
24. A method according to any one of Claims 9 to 18, wherein said substrate contains separated fractions of a sample.
25. A method according to Claim 23 for identifying locations of a specific separation product on the substrate, comprising the steps of:
(a) providing conditions permitting formation of nucleation centers at sites on said substrate comprising said specific separation product;
(b) contacting said substrate to a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising the composition being kinetically stable such that gold is deposited on the substrate essentially only where a nucleation center is present thereon, whereby upon such contact, gold atoms from said gold-providing agent are released and deposited onto said nucleation center; and (b) detecting presence of gold on said substrate, such gold signifying presence of said specific separation product on the substrate at a site where the gold is detected.
25. A method for assaying presence of an analyte in a sample comprising:
(a) providing a substrate carrying capturing agents which bind said analyze;
(b) contacting said substrate with said sample, whereby said analyte binds to said capturing agents;
(c) providing conditions permitting formation of nucleation centers on sites of said substrate comprising said analyze;
(d) contacting said substrate with a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers; and (e) detecting metallic gold deposits on said substrate, indicative of the presence of said analyte in said sample.
26. A method according to Claire 25, wherein step (c) comprises;
(c1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyze, coupled to at least one nucleation center being one or more of the group consisting of metal particle, cluster of metal atoms and a metal-containing complex; and (c2) contacting said substrate with said agents.
27. A method according to Claim 26, wherein said analyze is one of a binding couple consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain; and said at least one moiety is the other of said binding couple.
28. A method according to Claim 25 wherein step (b) comprises:
(b1) contacting said sample with nucleation centers, the nucleation centers being one or more of the group consisting of metal particles, cluster of metal atoms and metal-containing complexes or molecules, and providing conditions for coupling of said nucleation centers to the analyte if present in the sample, thus obtaining a modified sample containing modified analytes;
and (b2) contacting said substrate with said modified analytes bound to said nucleation centers.
29. A method according to Claim 28, wherein said analyte is one of a binding couple consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin;
cellulose or chitin and cellulose binding domain; and said capturing agent is the other of said binding couple.
30. A method according to any one of Claims 25 to 29, wherein said capturing agents are carried on the substrate between electrodes such that gold deposited onto said nucleation enters in step (d) establishes an electric contact between the electrodes; and detection of the gold deposits in step (c) is performed by measuring current-potential relationship between the electrodes.
30. A method according to any one of Claims 25 to 30, wherein said at least one metal particle, cluster of metal atoms or a metal-containing complex is a gold particle or cluster containing gold atoms.
32. A method according to any one of Claims 25 to 31, wherein said treatment composition is an aqueous solution.
33. A method according to Claim 32, wherein said gold providing agent is Au1(SCN)2.
34. A method according to Claim 32, wherein said reagent is a hydroquinone.
35. A kit for use in the method according to any one of Claims 1 to 34 36. A kit according to Claim 35, comprising a treatment composition which comprises a soluble gold-providing agent, being a gold-containing molecule or complex and comprises a reagent, the composition being kinetically stable such that upon contact with a substrate gold is deposited on a substrate essentially only at sifts of the substrate containing nucleation centers.
37. A kit according to Claim 35 or 35, further comprising nucleation center-forming agents, for forming nucleation centers at one or more sites on the substrate, said agents comprise each at least one {} member of a recognition group having a specific binding affinity to a substance present at said one or more sites coupled to at least one nucleation center moiety, being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex or molecule.
38. A kit for use in a method according to any one of Claims 25 to 34, for assaying an analyte in a sample, comprising:
(i) a substrate carrying capturing agents which bind said analyte;
(ii) agents for forming nucleation centers at portions of the substrate on which said analyte becomes immobilized;
(iii) a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers.
39. A kit according to Claim 3$, wherein said agent for forming nucleation centers comprises a nucleation center and substances needed in order to couple said nucleation center to said analyze.
40. A kit according to Claim 38, further comprising nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyte, coupled to at least one nucleation center moiety being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex.
41. A kit according to any one of Claims 38 to 40, wherein said substrate comprises two or more electrodes, and said capturing agents are carried within gaps between the electrodes.
1. A method for depositing gold at one or more sites on a substrate, comprising:
(a) binding, depositing or forming nucleation centers at said one or more sites; said nucleation centers comprising at least one member of a recognition group consisting of two or more {}molecules or complexes which bind {}to each other, the other member including or forming said one or more sites, coupled to at least one nucleation center being one or mere of the group consisting of metal particle, cluster containing metal atoms, a metal-containing complex and molecules.
(b) Contacting under appropriate conditions said one or more sites with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the substrate unless a nucleation center is present on the substrate and in the presence of a nucleation center at said one or more sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said one or mare sites.
2. A method according to Claim 1, wherein the one member of the recognition group is coupled to at last one nucleation center, being one or more of the group consisting of: cluster containing metal atoms and metal containing complexes and metals.
3. A method according to Claim 1, wherein the one member of the recognition group is coupled to at least one nucleation center being one or more of the group consisting of gold particle, cluster confining gold atoms and gold-containing complexes and molecules.
4. A method according to Claim 1, wherein the one member of the recognition group is coupled to at least one nucleation center being one or more of the group consisting of cluster containing gold atoms and gold-containing complexes and molecules.
5. A method according to Claim 1, wherein said {} recognition group is a member of the group consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent;
biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain.
6. A method according to any one of Claims 1 to 5, wherein said treatment composition is an aqueous solution.
7. A method according to Claim 6, wherein said gold-providing agent is Au1(SCN)2.
8. A method according to Claim 7, wherein said reagent is hydroquinone or naphtohydroqninone.
9. A method for assaying presence of a specific substance at sites on a substrate, comprising:
(a) providing conditions showing formation of nucleation centers on sites containing said substance;
(b) contacting said substrate with a treatment composition comprising a soluble gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited an the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to form gold metal deposits at said sites; and (c) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating presence of said substance at said site.
10. A method according to Claim 9, wherein step (a) comprises:
(a1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said substance, bound to at least one nucleation center being one or more of the group consisting of metal particle, cluster containing metal atoms and a metal-containing complex; and (a2) contacting said substrate with said agents.
11. A method according to Claim 10, wherein said moiety is included in one member of a recognition couple consisting of two molecules or complexes which specifically bind to one another, the other member included in or constituting said substance.
12. A method according to Claim 11, wherein said recognition couple is a member of the group consisting of an antigen and as antibody or an antibody derivative with as antigen binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain; said moiety being one of the recognition couple and said substance being or including the other.
13. A method according to any one of Claims 9-12, for assaying the presence of one or more target oligonucleotides with a specific target sequence in a sample, comprising:
(a) providing a substrate carrying one or more probe oligonucleotides each with a probing sequence complementary to one of said target sequences;
(b) contacting said substrate with the sample and providing conditions allowing formation of nucleation centers where a target oligonucleotide hybridizes to a probe oligonucleotide;
(c) contacting said substrate with a treatment composition comprising a gold providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that upon such exposure gold metal is essentially not deposited on the substrate unless a nucleation center is present thereon, and in the presence of a nucleation center at said sites, gold atoms are released from said gold-providing agent and deposited onto said nucleation center to forth gold metal deposits at said sites; and (d) detecting metallic gold deposits on said substrate, a gold deposit at a site on the substrate indicating the presence of said substance at said site.
14. A method according co Claim 13, wherein said step (b) comprises:
(b1) treating said sample to bind a label to oligonucleotides in the sample;
(b2) contacting said sample with said substrate; and (b3) contacting said substrate with a nucleation center-containing agent, capable of specific binding to said label.
15. A method according to Claim 13, wherein said step (b) comprises:
(b1) treating sand sample so as to bind nucleation centers to oligonucleotides present therein, and (b2) contacting said samples with said substrate.
16. A method according to any one of Claims 9 to 15, wherein said nucleation center is a gold particle a cluster containing gold atoms, or a gold-containing complex or molecules.
17. A method according to any one of Claims 9 to 16, wherein said treatment composition is an aqueous solution.
18. A method according so Claim 17, wherein said gold-providing agent is Au1(SCN)2 and said reagent is a quinone.
19. A method according to any one of Claims 9 to 18, wherein said substrate is a specimen for viewing in an imaging or visualization technique.
20. A method according to Claim 19, wherein the detention technique is based on light.
21. A method according to Claim 19, wherein the {} detection technique is based on light absorbance and/or light transmission and/or light reflectance and/or light scattering.
22. A method according to Claim 19, wherein said detection is made by techniques selected from: tansmission electron microscopy, scanning electron microscopy, atomic force microscopy.
23. A method according to Claim 19, for preparing the specimen for viewing in a microscope, comprising the following steps:
(a) providing conditions permitting formation of nucleation centers at selective sites of the specimen; and (b) contacting said specimen with a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising a reagent, the composition being kinetically stable such that gold is essentially not deposited on the specimen a nucleation center is present thereon, whereby gold atoms from said gold-providing agent are released and deposited onto said specimen at selective sites.
24. A method according to any one of Claims 9 to 18, wherein said substrate contains separated fractions of a sample.
25. A method according to Claim 23 for identifying locations of a specific separation product on the substrate, comprising the steps of:
(a) providing conditions permitting formation of nucleation centers at sites on said substrate comprising said specific separation product;
(b) contacting said substrate to a treatment composition comprising a soluble gold-providing agent, being a gold-containing molecule or complex and comprising the composition being kinetically stable such that gold is deposited on the substrate essentially only where a nucleation center is present thereon, whereby upon such contact, gold atoms from said gold-providing agent are released and deposited onto said nucleation center; and (b) detecting presence of gold on said substrate, such gold signifying presence of said specific separation product on the substrate at a site where the gold is detected.
25. A method for assaying presence of an analyte in a sample comprising:
(a) providing a substrate carrying capturing agents which bind said analyze;
(b) contacting said substrate with said sample, whereby said analyte binds to said capturing agents;
(c) providing conditions permitting formation of nucleation centers on sites of said substrate comprising said analyze;
(d) contacting said substrate with a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers; and (e) detecting metallic gold deposits on said substrate, indicative of the presence of said analyte in said sample.
26. A method according to Claire 25, wherein step (c) comprises;
(c1) providing nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyze, coupled to at least one nucleation center being one or more of the group consisting of metal particle, cluster of metal atoms and a metal-containing complex; and (c2) contacting said substrate with said agents.
27. A method according to Claim 26, wherein said analyze is one of a binding couple consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin; cellulose or chitin and cellulose binding domain; and said at least one moiety is the other of said binding couple.
28. A method according to Claim 25 wherein step (b) comprises:
(b1) contacting said sample with nucleation centers, the nucleation centers being one or more of the group consisting of metal particles, cluster of metal atoms and metal-containing complexes or molecules, and providing conditions for coupling of said nucleation centers to the analyte if present in the sample, thus obtaining a modified sample containing modified analytes;
and (b2) contacting said substrate with said modified analytes bound to said nucleation centers.
29. A method according to Claim 28, wherein said analyte is one of a binding couple consisting of an antigen and an antibody or an antibody derivative with an antigen-binding domain; sugar and a lectin; a receptor and a ligand; a nucleotide sequence and a complementary nucleotide sequence; a nucleotide sequence and its binding protein or other specific binding agent; biotin and avidin or streptavidin;
cellulose or chitin and cellulose binding domain; and said capturing agent is the other of said binding couple.
30. A method according to any one of Claims 25 to 29, wherein said capturing agents are carried on the substrate between electrodes such that gold deposited onto said nucleation enters in step (d) establishes an electric contact between the electrodes; and detection of the gold deposits in step (c) is performed by measuring current-potential relationship between the electrodes.
30. A method according to any one of Claims 25 to 30, wherein said at least one metal particle, cluster of metal atoms or a metal-containing complex is a gold particle or cluster containing gold atoms.
32. A method according to any one of Claims 25 to 31, wherein said treatment composition is an aqueous solution.
33. A method according to Claim 32, wherein said gold providing agent is Au1(SCN)2.
34. A method according to Claim 32, wherein said reagent is a hydroquinone.
35. A kit for use in the method according to any one of Claims 1 to 34 36. A kit according to Claim 35, comprising a treatment composition which comprises a soluble gold-providing agent, being a gold-containing molecule or complex and comprises a reagent, the composition being kinetically stable such that upon contact with a substrate gold is deposited on a substrate essentially only at sifts of the substrate containing nucleation centers.
37. A kit according to Claim 35 or 35, further comprising nucleation center-forming agents, for forming nucleation centers at one or more sites on the substrate, said agents comprise each at least one {} member of a recognition group having a specific binding affinity to a substance present at said one or more sites coupled to at least one nucleation center moiety, being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex or molecule.
38. A kit for use in a method according to any one of Claims 25 to 34, for assaying an analyte in a sample, comprising:
(i) a substrate carrying capturing agents which bind said analyte;
(ii) agents for forming nucleation centers at portions of the substrate on which said analyte becomes immobilized;
(iii) a treatment composition comprising a soluble gold-containing molecule or complex and a reagent, the composition being kinetically stable such that gold is deposited on the substrate essentially only at sites thereof containing the nucleation centers.
39. A kit according to Claim 3$, wherein said agent for forming nucleation centers comprises a nucleation center and substances needed in order to couple said nucleation center to said analyze.
40. A kit according to Claim 38, further comprising nucleation center-forming agents which comprise each at least one moiety, having specific binding affinity to said analyte, coupled to at least one nucleation center moiety being one or more of the group consisting of metal particle, cluster of metal atoms and a metal containing complex.
41. A kit according to any one of Claims 38 to 40, wherein said substrate comprises two or more electrodes, and said capturing agents are carried within gaps between the electrodes.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL126776 | 1998-10-27 | ||
| IL12677698A IL126776A (en) | 1998-10-27 | 1998-10-27 | Method for gold depositions |
| PCT/IL1999/000570 WO2000025136A1 (en) | 1998-10-27 | 1999-10-27 | Method for gold deposition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2348415A1 CA2348415A1 (en) | 2000-05-04 |
| CA2348415C true CA2348415C (en) | 2010-09-07 |
Family
ID=11072075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2348415A Expired - Fee Related CA2348415C (en) | 1998-10-27 | 1999-10-27 | Method for gold deposition |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7056748B1 (en) |
| EP (1) | EP1125128B1 (en) |
| JP (1) | JP4453856B2 (en) |
| CN (1) | CN1145028C (en) |
| AT (1) | ATE320002T1 (en) |
| AU (1) | AU759205B2 (en) |
| CA (1) | CA2348415C (en) |
| DE (1) | DE69930285T2 (en) |
| ES (1) | ES2263289T3 (en) |
| IL (1) | IL126776A (en) |
| RU (1) | RU2242005C2 (en) |
| WO (1) | WO2000025136A1 (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69737598T2 (en) | 1996-07-29 | 2007-12-27 | Nanosphere Inc., Skokie | NANOPARTICLES WITH OLIGONUCLEOTIDES ADDITED TO IT AND THEIR USES |
| US6582921B2 (en) | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
| US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US7098320B1 (en) | 1996-07-29 | 2006-08-29 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6750016B2 (en) | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6984491B2 (en) | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| IL121312A (en) | 1997-07-14 | 2001-09-13 | Technion Res & Dev Foundation | Microelectronic components, their fabrication and electronic networks comprising them |
| US6974669B2 (en) | 2000-03-28 | 2005-12-13 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified nanoparticles |
| IL124322A (en) * | 1998-05-04 | 2002-05-23 | Technion Res & Dev Foundation | Detection of an entity in a sample |
| IL126776A (en) | 1998-10-27 | 2001-04-30 | Technion Res & Dev Foundation | Method for gold depositions |
| US6399303B1 (en) | 1999-04-07 | 2002-06-04 | Integrated Nano-Technologies, Llc | High resolution DNA detection methods and devices |
| US7364920B2 (en) | 1999-10-27 | 2008-04-29 | Technion Research And Development Foundation Ltd. | Method for gold deposition |
| WO2001051665A2 (en) | 2000-01-13 | 2001-07-19 | Nanosphere Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6726847B2 (en) | 2000-12-06 | 2004-04-27 | Northwestern University | Silver stain removal by chemical etching and sonication |
| DE60228128D1 (en) | 2001-11-09 | 2008-09-18 | Nanosphere Inc | Bioconjugate NANOPARTICLE PROBES |
| EP1439392A3 (en) * | 2003-01-15 | 2005-07-27 | Agilent Technologies, Inc. | Biosensor systems and methods for determining the presence of biomolecules |
| DE10322912A1 (en) * | 2003-05-21 | 2004-12-16 | Bayer Technology Services Gmbh | Methods for the detection of nucleic acids |
| DE10328136A1 (en) * | 2003-06-23 | 2005-01-27 | Infineon Technologies Ag | Sensor element, sensor array and method for detecting particles possibly contained in an analyte |
| DE10330717A1 (en) * | 2003-07-03 | 2005-02-10 | Friedrich-Schiller-Universität Jena | Apparatus and method for detection of analyte |
| GB0812679D0 (en) | 2008-07-10 | 2008-08-20 | Sec Dep For Innovation Universities | Sample carrier for effecting chemical assays |
| ATE533054T1 (en) * | 2007-11-26 | 2011-11-15 | Sec Dep For Innovation Universities And Skills Of Her Majesty S Britannic Government | ELECTROCHEMICAL DETECTION WITH METAL MARKED DETECTION AGENT |
| ITTO20080632A1 (en) * | 2008-08-12 | 2010-02-13 | Consiglio Naz Delle Ricerche Infm Istituto | PROCEDURE FOR MICROMETRIC AND NANOMETRIC SCALE CONFIGURATION OF METALLIC LAYERS ON A SUBSTRATE |
| GB201217390D0 (en) | 2012-09-28 | 2012-11-14 | Agplus Diagnostics Ltd | Test device and sample carrier |
| RU2578977C1 (en) * | 2015-05-12 | 2016-03-27 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт глазных болезней" | Method of preparing biological sample for analysis by scanning electron microscopy |
| CN115951070A (en) * | 2023-01-19 | 2023-04-11 | 北京青莲百奥生物科技有限公司 | Method for detecting protein in sample |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3032436A (en) * | 1960-11-18 | 1962-05-01 | Metal Proc Co Inc | Method and composition for plating by chemical reduction |
| GB1343642A (en) * | 1971-04-28 | 1974-01-16 | May & Baker Ltd | Zinc sulphided pigments |
| US3833894A (en) | 1973-06-20 | 1974-09-03 | Ibm | Organic memory device |
| US4314821A (en) | 1979-04-09 | 1982-02-09 | Minnesota Mining And Manufacturing Company | Sandwich immunoassay using piezoelectric oscillator |
| US4323641A (en) * | 1980-08-15 | 1982-04-06 | The United States Of America As Represented By The Secretary Of The Navy | Photographic image enhancement by a gold-toning neutron-activation process |
| US5241060A (en) | 1982-06-23 | 1993-08-31 | Enzo Diagnostics, Inc. | Base moiety-labeled detectable nucleatide |
| GB8331514D0 (en) | 1983-11-25 | 1984-01-04 | Janssen Pharmaceutica Nv | Visualization method |
| US5202151A (en) | 1985-10-14 | 1993-04-13 | Hitachi, Ltd. | Electroless gold plating solution, method of plating with gold by using the same, and electronic device plated with gold by using the same |
| US4822566A (en) | 1985-11-19 | 1989-04-18 | The Johns Hopkins University | Optimized capacitive sensor for chemical analysis and measurement |
| US5137827A (en) * | 1986-03-25 | 1992-08-11 | Midwest Research Technologies, Inc. | Diagnostic element for electrical detection of a binding reaction |
| US4794089A (en) | 1986-03-25 | 1988-12-27 | Midwest Research Microscopy, Inc. | Method for electronic detection of a binding reaction |
| US5491098A (en) * | 1987-03-09 | 1996-02-13 | Janssen Pharmaceutica N.V. | Method for depositing metal particles on a marker |
| US5283174A (en) * | 1987-09-21 | 1994-02-01 | Gen-Probe, Incorporated | Homogenous protection assay |
| GB8800702D0 (en) | 1988-01-13 | 1988-02-10 | Nycomed As | Test method & reagent kit therefor |
| US5063417A (en) | 1988-07-18 | 1991-11-05 | California Institute Of Technology | Molecular shift register based on electron transfer |
| US4995402A (en) | 1988-10-12 | 1991-02-26 | Thorne, Smith, Astill Technologies, Inc. | Medical droplet whole blood and like monitoring |
| AU4647589A (en) | 1988-11-10 | 1990-05-28 | Midwest Research Technologies, Inc. | Method for electrical detection of a binding reaction |
| US5089545A (en) | 1989-02-12 | 1992-02-18 | Biotech International, Inc. | Switching and memory elements from polyamino acids and the method of their assembly |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| DE3924454A1 (en) | 1989-07-24 | 1991-02-07 | Cornelis P Prof Dr Hollenberg | THE APPLICATION OF DNA AND DNA TECHNOLOGY FOR THE CONSTRUCTION OF NETWORKS FOR USE IN CHIP CONSTRUCTION AND CHIP PRODUCTION (DNA CHIPS) |
| CA2026409C (en) | 1989-09-29 | 2004-11-09 | Ernest G. Schutt | Method of producing a reagent containing a narrow distribution of colloidal particles of a selected size and the use thereof |
| CA2034266A1 (en) | 1990-02-27 | 1991-08-28 | Paul A. D'orazio | Thick film reagent spreading and reagent immobilization layer |
| HU218095B (en) | 1990-05-01 | 2000-05-28 | Amgen Inc. | Process for reducing transitional contaminations in amplification processes |
| US5714327A (en) | 1990-07-19 | 1998-02-03 | Kreatech Diagnostics | Platinum-containing compounds, methods for their preparation and applications thereof |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| JP3064001B2 (en) | 1990-10-09 | 2000-07-12 | 株式会社アドバンス | Molecular fixation device |
| US5294369A (en) | 1990-12-05 | 1994-03-15 | Akzo N.V. | Ligand gold bonding |
| EP0495253B1 (en) * | 1991-01-15 | 1995-05-10 | Agfa-Gevaert N.V. | Method for the photographic production of silver images |
| JP2778304B2 (en) | 1991-09-17 | 1998-07-23 | 三菱電機株式会社 | Organic electronic device materials |
| JPH05105444A (en) * | 1991-09-25 | 1993-04-27 | Mitsubishi Materials Corp | Manufacture of spheroidal gold fine grain |
| US6051380A (en) | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
| US5787032A (en) | 1991-11-07 | 1998-07-28 | Nanogen | Deoxyribonucleic acid(DNA) optical storage using non-radiative energy transfer between a donor group, an acceptor group and a quencher group |
| IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
| US5846708A (en) | 1991-11-19 | 1998-12-08 | Massachusetts Institiute Of Technology | Optical and electrical methods and apparatus for molecule detection |
| GB9210176D0 (en) | 1992-05-12 | 1992-06-24 | Cemu Bioteknik Ab | Chemical method |
| JP3637056B2 (en) | 1992-06-01 | 2005-04-06 | エール ユニバシティ | Integrated circuit structure and method of manufacturing integrated circuit structure |
| US5331183A (en) | 1992-08-17 | 1994-07-19 | The Regents Of The University Of California | Conjugated polymer - acceptor heterojunctions; diodes, photodiodes, and photovoltaic cells |
| US5312527A (en) | 1992-10-06 | 1994-05-17 | Concordia University | Voltammetric sequence-selective sensor for target polynucleotide sequences |
| JPH08505778A (en) | 1993-01-21 | 1996-06-25 | ハイブライドン インコーポレイテッド | Foldback triplex forming oligonucleotide |
| US5384265A (en) * | 1993-03-26 | 1995-01-24 | Geo-Centers, Inc. | Biomolecules bound to catalytic inorganic particles, immunoassays using the same |
| US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
| US5837546A (en) | 1993-08-24 | 1998-11-17 | Metrika, Inc. | Electronic assay device and method |
| US5824473A (en) | 1993-12-10 | 1998-10-20 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US6071699A (en) | 1996-06-07 | 2000-06-06 | California Institute Of Technology | Nucleic acid mediated electron transfer |
| US5563424A (en) | 1994-03-24 | 1996-10-08 | Uniax Corporation | Polymer grid triodes |
| US5871918A (en) | 1996-06-20 | 1999-02-16 | The University Of North Carolina At Chapel Hill | Electrochemical detection of nucleic acid hybridization |
| AU720625B2 (en) * | 1995-03-10 | 2000-06-08 | Meso Scale Technologies, Llc | Multi-array, multi-specific electrochemiluminescence testing |
| US5679519A (en) * | 1995-05-09 | 1997-10-21 | Oprandy; John J. | Multi-label complex for enhanced sensitivity in electrochemiluminescence assay |
| US5614832A (en) | 1995-06-02 | 1997-03-25 | International Business Machines Corporation | High voltage protected ohmmeter |
| US5595878A (en) * | 1995-06-02 | 1997-01-21 | Boron Biologicals, Inc. | Detection of biopolymers and biooligomers with boron hydride labels |
| JPH0973780A (en) | 1995-09-01 | 1997-03-18 | Toshiba Corp | Semiconductor integrated circuit |
| US5888370A (en) | 1996-02-23 | 1999-03-30 | Board Of Regents, The University Of Texas System | Method and apparatus for fractionation using generalized dielectrophoresis and field flow fractionation |
| AU734086B2 (en) | 1996-05-22 | 2001-05-31 | Australian Membrane And Biotechnology Research Institute | Nucleic acid sensor |
| DE19622628A1 (en) | 1996-06-05 | 1997-12-11 | Boehringer Mannheim Gmbh | Stabilization of metal conjugates |
| US6750016B2 (en) | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6984491B2 (en) | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6582921B2 (en) | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
| US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| JPH1068730A (en) | 1996-08-27 | 1998-03-10 | Wako Pure Chem Ind Ltd | Test tool for immunochromatography |
| US5787332A (en) | 1996-09-26 | 1998-07-28 | Fansteel Inc. | Process for recovering tantalum and/or niobium compounds from composites containing a variety of metal compounds |
| US5874046A (en) | 1996-10-30 | 1999-02-23 | Raytheon Company | Biological warfare agent sensor system employing ruthenium-terminated oligonucleotides complementary to target live agent DNA sequences |
| US6306584B1 (en) | 1997-01-21 | 2001-10-23 | President And Fellows Of Harvard College | Electronic-property probing of biological molecules at surfaces |
| WO1998037417A1 (en) | 1997-02-20 | 1998-08-27 | The Regents Of The University Of California | Plasmon resonant particles, methods and apparatus |
| US5946550A (en) | 1997-03-14 | 1999-08-31 | University Of Connecticut | Self-assembled semiconductor and method of making same |
| US6391558B1 (en) | 1997-03-18 | 2002-05-21 | Andcare, Inc. | Electrochemical detection of nucleic acid sequences |
| US6210880B1 (en) | 1997-09-19 | 2001-04-03 | Third Wave Technologies, Inc. | Polymorphism analysis by nucleic acid structure probing with structure-bridging oligonucleotides |
| WO1998053841A1 (en) | 1997-05-27 | 1998-12-03 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon | Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters |
| IL121312A (en) | 1997-07-14 | 2001-09-13 | Technion Res & Dev Foundation | Microelectronic components, their fabrication and electronic networks comprising them |
| US20020025552A1 (en) | 1998-01-06 | 2002-02-28 | Institut Pasteur | Screening interactor molecules with whole genome oligonucleotide or polynucleotide arrays |
| WO1999036573A1 (en) | 1998-01-20 | 1999-07-22 | Schichman Steven A | Detection of genetic information |
| US6060023A (en) | 1998-03-31 | 2000-05-09 | Motorola, Inc. | Molecular sensing apparatus |
| IL124322A (en) | 1998-05-04 | 2002-05-23 | Technion Res & Dev Foundation | Detection of an entity in a sample |
| CA2328593C (en) | 1998-05-20 | 2011-07-12 | Integrated Nano-Technologies, Llc | Chemically assembled nano-scale devices |
| US6093370A (en) | 1998-06-11 | 2000-07-25 | Hitachi, Ltd. | Polynucleotide separation method and apparatus therefor |
| US6171870B1 (en) * | 1998-08-06 | 2001-01-09 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
| IL126776A (en) | 1998-10-27 | 2001-04-30 | Technion Res & Dev Foundation | Method for gold depositions |
| US6333146B1 (en) * | 1999-03-10 | 2001-12-25 | Fuji Photo Film Co., Ltd. | Methine compound and silver halide photographic material containing the same |
| US6399303B1 (en) | 1999-04-07 | 2002-06-04 | Integrated Nano-Technologies, Llc | High resolution DNA detection methods and devices |
| US7364920B2 (en) * | 1999-10-27 | 2008-04-29 | Technion Research And Development Foundation Ltd. | Method for gold deposition |
| AU7687001A (en) * | 2000-07-11 | 2002-01-21 | Nanospherre Inc | Method of detection by enhancement of silver staining |
| US6670113B2 (en) * | 2001-03-30 | 2003-12-30 | Nanoprobes | Enzymatic deposition and alteration of metals |
| US7266855B2 (en) * | 2002-06-04 | 2007-09-11 | Qingping Zhuan | Electric toothbrush |
| US7488607B2 (en) * | 2003-09-30 | 2009-02-10 | Agilent Technologies, Inc. | Electronically readable microarray with electronic addressing function |
| US20060014083A1 (en) * | 2004-03-01 | 2006-01-19 | University Of Washington | Methods and systems for fabricating electronic and/or microfluidic structures on elastomeric substrates |
-
1998
- 1998-10-27 IL IL12677698A patent/IL126776A/en not_active IP Right Cessation
-
1999
- 1999-10-27 RU RU2001114202/15A patent/RU2242005C2/en not_active IP Right Cessation
- 1999-10-27 JP JP2000578659A patent/JP4453856B2/en not_active Expired - Fee Related
- 1999-10-27 CA CA2348415A patent/CA2348415C/en not_active Expired - Fee Related
- 1999-10-27 AT AT99952775T patent/ATE320002T1/en not_active IP Right Cessation
- 1999-10-27 DE DE69930285T patent/DE69930285T2/en not_active Expired - Lifetime
- 1999-10-27 EP EP99952775A patent/EP1125128B1/en not_active Expired - Lifetime
- 1999-10-27 WO PCT/IL1999/000570 patent/WO2000025136A1/en active IP Right Grant
- 1999-10-27 ES ES99952775T patent/ES2263289T3/en not_active Expired - Lifetime
- 1999-10-27 US US09/830,457 patent/US7056748B1/en not_active Expired - Lifetime
- 1999-10-27 AU AU64859/99A patent/AU759205B2/en not_active Ceased
- 1999-10-27 CN CNB998148814A patent/CN1145028C/en not_active Expired - Fee Related
-
2003
- 2003-08-11 US US10/638,503 patent/US7851149B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000025136A1 (en) | 2000-05-04 |
| CN1145028C (en) | 2004-04-07 |
| JP4453856B2 (en) | 2010-04-21 |
| US7056748B1 (en) | 2006-06-06 |
| EP1125128B1 (en) | 2006-03-08 |
| IL126776A (en) | 2001-04-30 |
| CA2348415A1 (en) | 2000-05-04 |
| IL126776A0 (en) | 1999-08-17 |
| US20040033626A1 (en) | 2004-02-19 |
| AU6485999A (en) | 2000-05-15 |
| EP1125128A1 (en) | 2001-08-22 |
| US7851149B2 (en) | 2010-12-14 |
| AU759205B2 (en) | 2003-04-10 |
| ES2263289T3 (en) | 2006-12-01 |
| DE69930285D1 (en) | 2006-05-04 |
| ATE320002T1 (en) | 2006-03-15 |
| CN1331800A (en) | 2002-01-16 |
| DE69930285T2 (en) | 2006-12-07 |
| JP2002528098A (en) | 2002-09-03 |
| RU2242005C2 (en) | 2004-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2348415C (en) | Method for gold deposition | |
| US7985539B2 (en) | Nanoparticle probes with raman spectroscopic fingerprints for analyte detection | |
| de la Escosura-Muñiz et al. | Electrochemical analysis with nanoparticle-based biosystems | |
| CA2641613C (en) | Detection of a target in a sample | |
| US6878539B1 (en) | Affinity sensor for detecting specific molecular binding events and use thereof | |
| IE69371B1 (en) | Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets | |
| EP2121974A1 (en) | Detecting analytes using both an optical and an electrical measurement method | |
| US20030087277A1 (en) | Means and methods for detection of binding of members of specific binding pairs | |
| KR101075760B1 (en) | Apparatus and methods for detecting dna in biological samples | |
| US7364920B2 (en) | Method for gold deposition | |
| US20050255515A1 (en) | Biomolecular sensors and detection methods utilizing photoinduced charge separation | |
| KR20180094680A (en) | A method for detection of a target analyte using gold nano-probe by copper crystal overgrowth | |
| MXPA01004280A (en) | Method for gold deposition | |
| JP4017420B2 (en) | Biological component detection method | |
| Wang et al. | Genomagnetic electrochemical biosensors | |
| JOSEPH et al. | GENOMAGNETIC ELECTROCHEMICAL BIOSENSORS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20181029 |